Loading...
Emerging therapies for inv(16) AML
The core binding factor composed of CBFβ and RUNX subunits plays a critical role in most hematopoietic lineages and is deregulated in acute myeloid leukemia (AML). The fusion oncogene CBFβ-SMMHC expressed in AML with the chromosome inversion inv(16)(p13q22) acts as a driver oncogene in hematopoietic...
Saved in:
| Published in: | Blood |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Hematology
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120144/ https://ncbi.nlm.nih.gov/pubmed/33821975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020009933 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|